| # | Title | Journal | Year | Citations |
|---|
| 1 | Inflammation and cardiovascular disease: From mechanisms to therapeutics | American Journal of Preventive Cardiology | 2020 | 142 |
| 2 | Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology | American Journal of Preventive Cardiology | 2020 | 90 |
| 3 | Ten things to know about ten cardiovascular disease risk factors | American Journal of Preventive Cardiology | 2021 | 87 |
| 4 | Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement | American Journal of Preventive Cardiology | 2022 | 58 |
| 5 | Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention | American Journal of Preventive Cardiology | 2020 | 54 |
| 6 | Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement | American Journal of Preventive Cardiology | 2021 | 51 |
| 7 | Stroke in young adults: Current trends, opportunities for prevention and pathways forward | American Journal of Preventive Cardiology | 2020 | 35 |
| 8 | Ten things to know about ten cardiovascular disease risk factors – 2022 | American Journal of Preventive Cardiology | 2022 | 34 |
| 9 | Top 10 dietary strategies for atherosclerotic cardiovascular risk reduction | American Journal of Preventive Cardiology | 2020 | 29 |
| 10 | Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice Statement | American Journal of Preventive Cardiology | 2022 | 27 |
| 11 | Physical activity, cardiorespiratory fitness, and cardiovascular health: A clinical practice statement of the American Society for Preventive Cardiology Part I: Bioenergetics, contemporary physical activity recommendations, benefits, risks, extreme exercise regimens, potential maladaptations | American Journal of Preventive Cardiology | 2022 | 24 |
| 12 | Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease | American Journal of Preventive Cardiology | 2021 | 23 |
| 13 | There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness | American Journal of Preventive Cardiology | 2022 | 23 |
| 14 | Meta-analysis of effect of vegetarian diet on ischemic heart disease and all-cause mortality | American Journal of Preventive Cardiology | 2021 | 22 |
| 15 | Aspirin for cardiovascular disease prevention among adults in the United States: Trends, prevalence, and participant characteristics associated with use | American Journal of Preventive Cardiology | 2021 | 22 |
| 16 | Age and sex disparities in hypertension control: The multi-ethnic study of atherosclerosis (MESA) | American Journal of Preventive Cardiology | 2021 | 22 |
| 17 | GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases | American Journal of Preventive Cardiology | 2020 | 21 |
| 18 | The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: Results from the VIPVIZA randomized clinical trial | American Journal of Preventive Cardiology | 2021 | 21 |
| 19 | Medicine 2032: The future of cardiovascular disease prevention with machine learning and digital health technology | American Journal of Preventive Cardiology | 2022 | 21 |
| 20 | Heterogeneity in cardio-metabolic risk factors and atherosclerotic cardiovascular disease among Asian groups in the United States | American Journal of Preventive Cardiology | 2021 | 20 |
| 21 | Improving cardiovascular health in black men through a 24-week community-based team lifestyle change intervention: The black impact pilot study | American Journal of Preventive Cardiology | 2022 | 20 |
| 22 | U.S. population at increased risk of severe illness from COVID-19 | American Journal of Preventive Cardiology | 2021 | 19 |
| 23 | COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD | American Journal of Preventive Cardiology | 2021 | 19 |
| 24 | Physical activity and sedentary behaviour in secondary prevention of coronary artery disease: A review | American Journal of Preventive Cardiology | 2021 | 18 |
| 25 | Health disparities in cardiometabolic risk among Black and Hispanic youth in the United States | American Journal of Preventive Cardiology | 2021 | 18 |
| 26 | Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States | American Journal of Preventive Cardiology | 2020 | 17 |
| 27 | Lipid treatment status and goal attainment among patients with atherosclerotic cardiovascular disease in the United States: A 2019 update | American Journal of Preventive Cardiology | 2022 | 17 |
| 28 | Thirty percent of children and young adults with familial hypercholesterolemia treated with statins have adherence issues | American Journal of Preventive Cardiology | 2021 | 16 |
| 29 | The impact of mental health conditions on oral anticoagulation therapy and outcomes in patients with atrial fibrillation: A systematic review and meta-analysis | American Journal of Preventive Cardiology | 2021 | 16 |
| 30 | Income disparity and utilization of cardiovascular preventive care services among U.S. adults | American Journal of Preventive Cardiology | 2021 | 16 |
| 31 | Cardiac CT angiography in current practice: An American society for preventive cardiology clinical practice statement✰ | American Journal of Preventive Cardiology | 2022 | 16 |
| 32 | Physical activity, cardiorespiratory fitness, and cardiovascular health: A clinical practice statement of the American Society for Preventive Cardiology Part II: Physical activity, cardiorespiratory fitness, minimum and goal intensities for exercise training, prescriptive methods, and special patient populations | American Journal of Preventive Cardiology | 2022 | 16 |
| 33 | State-of-the-Art review: Hypertension practice guidelines in the era of COVID-19 | American Journal of Preventive Cardiology | 2020 | 15 |
| 34 | Association of income and educational attainment in hospitalization events in atrial fibrillation | American Journal of Preventive Cardiology | 2021 | 15 |
| 35 | Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysis | American Journal of Preventive Cardiology | 2021 | 15 |
| 36 | The food pharmacy: Theory, implementation, and opportunities | American Journal of Preventive Cardiology | 2021 | 14 |
| 37 | The landscape of preventive cardiology in Turkey: Challenges and successes | American Journal of Preventive Cardiology | 2021 | 14 |
| 38 | Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statins | American Journal of Preventive Cardiology | 2021 | 14 |
| 39 | Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocol | American Journal of Preventive Cardiology | 2020 | 13 |
| 40 | Cardiovascular risk assessment: The foundation of preventive cardiology | American Journal of Preventive Cardiology | 2020 | 13 |
| 41 | Cardiovascular-related health behaviors and lifestyle during the COVID-19 pandemic: An infodemiology study | American Journal of Preventive Cardiology | 2021 | 13 |
| 42 | Knowledge and perception of cardiovascular disease risk in women of reproductive age | American Journal of Preventive Cardiology | 2022 | 13 |
| 43 | Progression of coronary atherosclerosis in patients without standard modifiable risk factors | American Journal of Preventive Cardiology | 2020 | 12 |
| 44 | Trends in cholesterol testing during the COVID-19 pandemic | American Journal of Preventive Cardiology | 2021 | 12 |
| 45 | A proof-of-concept study of cascade screening for Familial Hypercholesterolemia in the US, adapted from the Dutch model | American Journal of Preventive Cardiology | 2021 | 12 |
| 46 | Trends in prepregnancy cardiovascular health in the United States, 2011–2019 | American Journal of Preventive Cardiology | 2021 | 12 |
| 47 | Oral health and atherosclerotic cardiovascular disease: A review | American Journal of Preventive Cardiology | 2021 | 12 |
| 48 | Intensive lipid lowering agents and coronary atherosclerosis: Insights from intravascular imaging | American Journal of Preventive Cardiology | 2022 | 12 |
| 49 | AHA Life's essential 8 and ideal cardiovascular health among young adults | American Journal of Preventive Cardiology | 2023 | 12 |
| 50 | Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States | American Journal of Preventive Cardiology | 2021 | 11 |
